| - GRCh37:
- Chr2:223158963
- GRCh38:
- Chr2:222294244
| PAX3 | A170D, A169D | Waardenburg syndrome type 1 | Uncertain significance | criteria provided, single submitter |
| - GRCh37:
- Chr2:223096987
- GRCh38:
- Chr2:222232268
| PAX3 | S200*, S201* | Waardenburg syndrome type 1 | Likely pathogenic (Jul 1, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr2:223096901
- GRCh38:
- Chr2:222232182
| PAX3 | Q229K, Q230K | Waardenburg syndrome type 1 | Likely pathogenic (Mar 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:222902251-226084516
| ACSL3, AP1S3, CCDC140, CUL3, DOCK10, FAM124B, FARSB, KCNE4, MOGAT1, MRPL44, PAX3, SCG2, SERPINE2, SGPP2, WDFY1 | | Waardenburg syndrome type 1 | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr2:223096906
- GRCh38:
- Chr2:222232187
| PAX3 | A227V, A228V | Craniofacial-deafness-hand syndrome, Waardenburg syndrome type 1, Waardenburg syndrome type 3
| Uncertain significance (Jun 23, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:223096821
- GRCh38:
- Chr2:222232102
| PAX3 | K256fs, K257fs | Waardenburg syndrome type 1 | Likely pathogenic (May 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:223096876
- GRCh38:
- Chr2:222232157
| PAX3 | F237S, F238S | Waardenburg syndrome type 1 | Pathogenic (May 20, 2022) | no assertion criteria provided |
| - GRCh37:
- Chr2:223086090
- GRCh38:
- Chr2:222221371
| PAX3 | R269P, R270P | Waardenburg syndrome type 1 | Likely pathogenic (Aug 12, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr2:223084996
- GRCh38:
- Chr2:222220277
| LOC126806529, PAX3 | S345P, S346P | not provided, Alveolar rhabdomyosarcoma, Waardenburg syndrome type 3, Waardenburg syndrome type 1, Craniofacial-deafness-hand syndrome | Uncertain significance (Dec 9, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:223161816
- GRCh38:
- Chr2:222297097
| PAX3 | R68W | Waardenburg syndrome type 1 | Likely pathogenic (Aug 1, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:223158884
- GRCh38:
- Chr2:222294165
| PAX3 | | Waardenburg syndrome type 1 | Pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr2:223161737
- GRCh38:
- Chr2:222297018
| PAX3 | G94V | Waardenburg syndrome type 1 | Likely pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr2:223160325-223160326
- GRCh38:
- Chr2:222295606-222295607
| PAX3 | N124fs, N125fs | Waardenburg syndrome type 1 | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr22:38379525
- GRCh38:
- Chr22:37983518
| POLR2F, SOX10 | M90fs | PCWH syndrome, Waardenburg syndrome type 1 | Pathogenic (Apr 26, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr22:38379492-38379493
- GRCh38:
- Chr22:37983485-37983486
| POLR2F, SOX10 | S100fs | Waardenburg syndrome type 1 | Pathogenic (Apr 26, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr22:38379370
- GRCh38:
- Chr22:37983363
| POLR2F, SOX10 | L141P | Waardenburg syndrome type 1 | Likely pathogenic (Apr 26, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr22:38379456
- GRCh38:
- Chr22:37983449
| POLR2F, SOX10 | M112I | Waardenburg syndrome type 1 | Pathogenic (Apr 26, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr22:38379416-38379426
- GRCh38:
- Chr22:37983409-37983419
| POLR2F, SOX10 | A123fs | Waardenburg syndrome type 1 | Pathogenic (Apr 26, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr22:38379457
- GRCh38:
- Chr22:37983450
| POLR2F, SOX10 | M112T | Waardenburg syndrome type 1 | Likely pathogenic (Apr 26, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr2:223160331-223160332
- GRCh38:
- Chr2:222295612-222295613
| PAX3 | N124fs, N125fs | Waardenburg syndrome type 1 | Pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr2:223161852
- GRCh38:
- Chr2:222297133
| PAX3 | R56C | Waardenburg syndrome type 1 | Likely pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr2:223161895
- GRCh38:
- Chr2:222297176
| PAX3 | G42fs | Waardenburg syndrome type 1 | Pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr2:223065952
- GRCh38:
- Chr2:222201233
| PAX3 | Q487* | Waardenburg syndrome type 1 | Pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr2:223161875
- GRCh38:
- Chr2:222297156
| PAX3 | G48fs | Waardenburg syndrome type 1 | Pathogenic (Jan 1, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr2:222199886-222298997
| EPHA4, PAX3 | | Waardenburg syndrome type 1 | Pathogenic (Jan 1, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr2:223085973-223085974
- GRCh38:
- Chr2:222221254-222221255
| PAX3 | E308fs, E309fs | Waardenburg syndrome type 1 | Pathogenic (Jan 1, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr2:223096834
- GRCh38:
- Chr2:222232115
| PAX3 | L251P, L252P | Waardenburg syndrome type 1 | Likely pathogenic (Jan 1, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr2:223096883
- GRCh38:
- Chr2:222232164
| PAX3 | R235S, R236S | Waardenburg syndrome type 1 | Pathogenic (Jan 1, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr2:223096918
- GRCh38:
- Chr2:222232199
| PAX3 | T223I, T224I | Waardenburg syndrome type 1 | Pathogenic (Jan 1, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr2:223161754
- GRCh38:
- Chr2:222297035
| PAX3 | | Waardenburg syndrome type 1 | Pathogenic (Jan 1, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr2:223161777
- GRCh38:
- Chr2:222297058
| PAX3 | G81R | Waardenburg syndrome type 1 | Pathogenic (Jan 1, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr2:223161748
- GRCh38:
- Chr2:222297029
| PAX3 | Y90* | Intellectual disability, not provided, Waardenburg syndrome type 1
| Pathogenic/Likely pathogenic (Jan 23, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:223161891
- GRCh38:
- Chr2:222297172
| PAX3 | G43C | Waardenburg syndrome type 1 | Pathogenic (Feb 26, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr22:38369723-38369724
- GRCh38:
- Chr22:37973716-37973717
| POLR2F, SOX10 | S394fs | not provided | Likely pathogenic (Jul 26, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:223161779
- GRCh38:
- Chr2:222297060
| PAX3 | H80R | Waardenburg syndrome type 1 | Likely pathogenic (May 28, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr2:223066124
- GRCh38:
- Chr2:222201405
| PAX3 | | Waardenburg syndrome type 1 | Uncertain significance (Jan 29, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr2:223084955-223084956
- GRCh38:
- Chr2:222220236-222220237
| LOC126806529, PAX3 | T359fs, T358fs | Waardenburg syndrome type 1 | Pathogenic (Dec 26, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr2:223066707-223066708
- GRCh38:
- Chr2:222201988-222201989
| PAX3 | S459fs, S458fs | Waardenburg syndrome type 1 | Likely pathogenic (Nov 1, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr2:223066806
- GRCh38:
- Chr2:222202087
| PAX3 | S426*, S425* | Waardenburg syndrome type 1 | Likely pathogenic (Nov 1, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr2:223085011
- GRCh38:
- Chr2:222220292
| LOC126806529, PAX3 | Q341*, Q340* | Waardenburg syndrome type 1 | Likely pathogenic (Nov 1, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr2:223085978
- GRCh38:
- Chr2:222221259
| PAX3 | S307fs, S308fs | Waardenburg syndrome type 1 | Likely pathogenic (Nov 1, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr2:223086081
- GRCh38:
- Chr2:222221362
| PAX3 | R273K, R272K | Waardenburg syndrome type 1 | Uncertain significance (Nov 1, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr2:223086088
- GRCh38:
- Chr2:222221369
| PAX3 | R271C, R270C | not provided, Waardenburg syndrome type 1 | Pathogenic (Aug 31, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:223086091
- GRCh38:
- Chr2:222221372
| PAX3 | R270C, R269C | not provided, Waardenburg syndrome type 1 | Pathogenic/Likely pathogenic (Jan 24, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:223096798
- GRCh38:
- Chr2:222232079
| PAX3 | Q264P, Q263P | Waardenburg syndrome type 1 | Likely pathogenic (Nov 1, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr2:223096859
- GRCh38:
- Chr2:222232140
| PAX3 | P244S, P243S | Waardenburg syndrome type 1 | Uncertain significance (Nov 1, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr2:223096897
- GRCh38:
- Chr2:222232178
| PAX3 | L231P, L230P | Waardenburg syndrome type 1 | Likely pathogenic (Nov 1, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr2:223158941-223158942
- GRCh38:
- Chr2:222294222-222294223
| PAX3 | | Waardenburg syndrome type 1 | Likely pathogenic (Nov 1, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr2:223158947-223158948
- GRCh38:
- Chr2:222294228-222294229
| PAX3 | E176fs, E175fs | Waardenburg syndrome type 1 | Likely pathogenic (Nov 1, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr2:223158988-223158990
- GRCh38:
- Chr2:222294269-222294271
| PAX3 | K161fs, K160fs | Waardenburg syndrome type 1 | Likely pathogenic (Nov 1, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr2:223159029
- GRCh38:
- Chr2:222294310
| PAX3 | | not provided, Waardenburg syndrome type 1 | Conflicting interpretations of pathogenicity (Nov 27, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:223161725
- GRCh38:
- Chr2:222297006
| PAX3 | P98L | Waardenburg syndrome type 1 | Uncertain significance (Nov 1, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr2:223161749
- GRCh38:
- Chr2:222297030
| PAX3 | Y90C | Waardenburg syndrome type 1 | Likely pathogenic (Nov 1, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr2:223161772
- GRCh38:
- Chr2:222297053
| PAX3 | C82* | Waardenburg syndrome type 1 | Likely pathogenic (Nov 1, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr2:223161786
- GRCh38:
- Chr2:222297067
| PAX3 | V78L | Waardenburg syndrome type 1 | Likely pathogenic (Nov 1, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr2:223161791
- GRCh38:
- Chr2:222297072
| PAX3 | L76R | Waardenburg syndrome type 1 | Uncertain significance (Nov 1, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr2:223161800
- GRCh38:
- Chr2:222297081
| PAX3 | S73L | Waardenburg syndrome type 1 | Pathogenic (Nov 1, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr2:223161808
- GRCh38:
- Chr2:222297089
| PAX3 | C70* | not provided, Waardenburg syndrome type 1 | Pathogenic/Likely pathogenic (Sep 23, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:223161881-223161882
- GRCh38:
- Chr2:222297162-222297163
| PAX3 | I46fs | not provided, Waardenburg syndrome type 1 | Pathogenic/Likely pathogenic (Jul 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:223161934
- GRCh38:
- Chr2:222297215
| PAX3 | | not provided, Waardenburg syndrome type 1 | Pathogenic/Likely pathogenic (Sep 2, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:223161762
- GRCh38:
- Chr2:222297043
| PAX3 | I86F | Waardenburg syndrome type 1 | Likely pathogenic (May 15, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr2:223066853
- GRCh38:
- Chr2:222202134
| PAX3 | Y410*, Y409* | Waardenburg syndrome type 1 | Pathogenic (May 15, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr3:70005682
- GRCh38:
- Chr3:69956531
| MITF | | not provided, Waardenburg syndrome type 2A | Pathogenic (Sep 25, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:223086019-223086020
- GRCh38:
- Chr2:222221300-222221301
| PAX3 | F294fs, F293fs | not provided, Rare genetic deafness, Waardenburg syndrome, Waardenburg syndrome type 1 | Pathogenic (Sep 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:223158932
- GRCh38:
- Chr2:222294213
| PAX3 | S180R, S179R | not specified, Waardenburg syndrome type 3, Alveolar rhabdomyosarcoma, Waardenburg syndrome type 1, Craniofacial-deafness-hand syndrome | Uncertain significance (Oct 31, 2018) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:223158892
- GRCh38:
- Chr2:222294173
| PAX3 | E194K, E193K | not provided, Waardenburg syndrome type 1, Craniofacial-deafness-hand syndrome, Alveolar rhabdomyosarcoma, Waardenburg syndrome type 3, Waardenburg syndrome, not specified, Craniofacial-deafness-hand syndrome | Conflicting interpretations of pathogenicity (May 25, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:223096922
- GRCh38:
- Chr2:222232203
| PAX3 | R223*, R222* | Waardenburg syndrome type 1, Waardenburg syndrome type 3, not provided
| Pathogenic (May 26, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:223066888
- GRCh38:
- Chr2:222202169
| PAX3 | H399D, H398D | Waardenburg syndrome type 1 | Likely benign (Mar 1, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr2:223161876
- GRCh38:
- Chr2:222297157
| PAX3 | G48R | Waardenburg syndrome type 1, not provided | Pathogenic/Likely pathogenic (Jul 11, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:223159008
- GRCh38:
- Chr2:222294289
| PAX3 | S155fs, S154fs | Waardenburg syndrome type 1 | Likely pathogenic (Mar 1, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr2:223096799
- GRCh38:
- Chr2:222232080
| PAX3 | Q264*, Q263* | Waardenburg syndrome type 1 | Likely pathogenic (Mar 1, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr2:223161858-223161869
- GRCh38:
- Chr2:222297139-222297150
| PAX3 | | Waardenburg syndrome type 1 | Likely pathogenic (Mar 1, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr2:223161894
- GRCh38:
- Chr2:222297175
| PAX3 | G42R | Waardenburg syndrome type 1, Intellectual disability, not provided
| Likely pathogenic (Oct 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:223096850-223096862
- GRCh38:
- Chr2:222232131-222232143
| PAX3 | Y242fs, Y243fs | Waardenburg syndrome type 1 | Likely pathogenic (Mar 1, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr2:223161876
- GRCh38:
- Chr2:222297157
| PAX3 | G48C | Waardenburg syndrome type 1, Waardenburg syndrome type 3 | Conflicting interpretations of pathogenicity (Dec 14, 2021) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:223096805
- GRCh38:
- Chr2:222232086
| PAX3 | R262*, R261* | not provided, Waardenburg syndrome type 1 | Pathogenic (Jan 1, 2019) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:223086087
- GRCh38:
- Chr2:222221368
| PAX3 | R271H, R270H | Alveolar rhabdomyosarcoma, Craniofacial-deafness-hand syndrome, Waardenburg syndrome type 1, Waardenburg syndrome type 3, not provided, Waardenburg syndrome type 1
| Pathogenic (Jun 7, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:223160283
- GRCh38:
- Chr2:222295564
| PAX3 | K139*, K138* | Waardenburg syndrome type 1 | Pathogenic (Mar 10, 2016) | no assertion criteria provided |
| - GRCh37:
- Chr2:223158947
- GRCh38:
- Chr2:222294228
| PAX3 | K175N, K174N | Waardenburg syndrome, not specified, Waardenburg syndrome type 1, Craniofacial-deafness-hand syndrome, not provided | Benign/Likely benign (Sep 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:223085955
- GRCh38:
- Chr2:222221236
| PAX3 | T315K, T314K | Waardenburg syndrome type 1, Craniofacial-deafness-hand syndrome, Waardenburg syndrome, not specified, not provided, Congenital diaphragmatic hernia
| Conflicting interpretations of pathogenicity (Nov 3, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:223161889
- GRCh38:
- Chr2:222297170
| PAX3 | | Waardenburg syndrome, not specified, not provided, Waardenburg syndrome type 1, Waardenburg syndrome type 3, Craniofacial-deafness-hand syndrome
| Benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:223161777
- GRCh38:
- Chr2:222297058
| PAX3 | G81C | not provided, Waardenburg syndrome type 1 | Conflicting interpretations of pathogenicity (Oct 13, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:223158916
- GRCh38:
- Chr2:222294197
| PAX3 | H186fs, H185fs | Waardenburg syndrome type 1 | Pathogenic (Mar 1, 2012) | no assertion criteria provided |
| - GRCh37:
- Chr2:223161780
- GRCh38:
- Chr2:222297061
| PAX3 | H80D | Waardenburg syndrome type 1 | Pathogenic (Mar 1, 2012) | no assertion criteria provided |
| - GRCh37:
- Chr2:223161851
- GRCh38:
- Chr2:222297132
| PAX3 | R56L | Waardenburg syndrome, not provided | Pathogenic/Likely pathogenic (Sep 1, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:223161767
- GRCh38:
- Chr2:222297048
| PAX3 | S84F | Waardenburg syndrome type 1 | Pathogenic (Aug 1, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:223160329-223160333
- GRCh38:
- Chr2:222295610-222295614
| PAX3 | K122fs, K121fs | Waardenburg syndrome type 1 | Pathogenic (Jan 1, 1995) | no assertion criteria provided |
| - GRCh37:
- Chr2:223161776
- GRCh38:
- Chr2:222297057
| PAX3 | G81A | not provided | Pathogenic (Aug 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:223158913-223158914
- GRCh38:
- Chr2:222294194-222294195
| PAX3 | H185fs, H186fs | not provided | Pathogenic (Feb 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:223161730
- GRCh38:
- Chr2:222297011
| PAX3 | R97fs | Waardenburg syndrome type 1 | Pathogenic (Jan 1, 1993) | no assertion criteria provided |
| - GRCh37:
- Chr2:223161737-223161750
- GRCh38:
- Chr2:222297018-222297031
| PAX3 | Y90fs | Waardenburg syndrome type 1 | Pathogenic (Jul 1, 1992) | no assertion criteria provided |
| - GRCh37:
- Chr2:223161869
- GRCh38:
- Chr2:222297150
| PAX3 | P50L | Waardenburg syndrome type 1 | Pathogenic (Feb 13, 1992) | no assertion criteria provided |
| - GRCh37:
- Chr2:223161816-223161833
- GRCh38:
- Chr2:222297097-222297114
| PAX3 | | Waardenburg syndrome type 1 | Pathogenic (Feb 13, 1992) | no assertion criteria provided |